How to use Technology Searches
The `Technologies Searched´-section displays profiles of unmet needs covering a broad spectrum from scientific expertise to clinical stage product candidates. Text search allows the use of phrases not yet part of our category lists. Key words can be used in combination and help identifying the hits most relevant for you.
A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in `Sector´, "Cancerous, neoplasmatic" in `Disease Category, "Drugs, Small Molecule" in `Technology´ and "Preclinical" in `Development Stage. Selection of "Enabling Technology, Platform technology" in `Sector´ will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee. Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.
Summary
Ferring is seeking late stage products in the area of gastroenterology
Organization name
Ferring business development
Profile
Ferring´s primary business development objective is to strengthen the company´s existing core therapeutic areas through global in-licensing and acquisitions. In addition, a key strategic objective is to grow their existing business in the United States.
To that end Ferring is looking to pursue its business goals by building alliances with other companies or acquiring new products. In particular the company is interested in late stage products (phase III) as well as products already marketed globally and regionally.
Ferring is actively seeking products in the area of gastroenterology.
Over the next few years Ferring
- will be looking for a product to supplement PENTASA for the treatment of moderate to severe Crohn´s disease and ulcerative colitis.
- is interested in new treatment options for inflammatory bowel diseases.
- is looking to develop the next generation of the GLYPRESSIN-inspired treatments.
URL
http://www.ferring.com/busdev/Who+to+Contact/Your feedback
back
print this page
